Related Experiment Video
Updated: May 3, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
1.3K
Thyrotropinoma and multinodular goiter: A diagnostic challenge for hyperthyroidism.
Duygu Yazgan Aksoy1, Arzu Gedik2, Nese Cinar1
1Department of Internal Medicine, Section of Endocrinology and Metabolism, Medical School, Hacettepe University, Ankara, Turkey.
Summary
Thyrotropinoma, a rare cause of hyperthyroidism, presents subtly. This case highlights diagnostic challenges with co-secreting hormones and multinodular goiter, leading to atypical hyperthyroid presentations.
Area of Science:
- Endocrinology
- Oncology
- Internal Medicine
Background:
- Thyroid disorders are common, but diagnosis can be complex when findings are inconclusive.
- Hyperthyroidism caused by a thyrotropin-secreting pituitary adenoma (thyrotropinoma) is rare and often presents with subtle symptoms.
- Atypical presentations arise with co-secretion of other pituitary hormones or coexisting thyroid parenchymal disease.
Observation:
- A 63-year-old female patient presented with a thyrotropinoma co-secreting growth hormone.
- The patient had a history of multinodular goiter.
- She developed hyperthyroidism sequentially, first from the thyrotropinoma and subsequently from a toxic nodule within the goiter.
Findings:
- The co-secretion of growth hormone and multinodular goiter complicated the diagnosis of hyperthyroidism.
- The patient experienced a dual etiology of hyperthyroidism, posing unique clinical and laboratory challenges.
- Subtle initial symptoms of thyroid hormone excess masked the underlying pituitary and thyroid pathology.
Implications:
- This case underscores the importance of considering rare pituitary tumors in the differential diagnosis of hyperthyroidism, especially with atypical features.
- Managing hyperthyroidism in patients with coexisting pituitary adenomas and thyroid pathologies requires a comprehensive and individualized approach.
- Further research into the diagnostic and therapeutic strategies for complex hyperthyroid cases is warranted to improve patient outcomes.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Goiter
32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Hypothyroidism II: Pathophysiology
26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26

